New eye drops aim to soothe itchy, damaged eyes from rare allergy condition
Symptom relief
Recruiting now
This study tests an experimental eye drop, DFL24498, against a placebo in 138 adults with atopic keratoconjunctivitis (AKC), a severe allergic eye disease. The main goal is to see if the drops reduce eye itching and corneal damage over 6 weeks. Participants must have AKC in both …
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC